Cover Image
市場調查報告書

全球兒童質子治療市場、預測 (10個國家的市場資料)

Global Pediatric Proton Therapy Market & Forecast (10 Countries Market Data), Patients Treated

出版商 Renub Research 商品編碼 543297
出版日期 內容資訊 英文 330 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球兒童質子治療市場、預測 (10個國家的市場資料) Global Pediatric Proton Therapy Market & Forecast (10 Countries Market Data), Patients Treated
出版日期: 2017年08月11日 內容資訊: 英文 330 Pages
簡介

全球兒童質子治療市場規模,預計至2021年達到7億美元以上。兒童癌症發病率的增加及為了患者每人更快速治療的技術改善,促進全球兒童質子治療市場。

本報告提供全球質子治療市場 (主要10個國家)的 調查分析,市場現狀與未來的成長可能性,年齡族群、腫瘤的各種類、各國的患者數,在醫療費償付政策,及質子治療中心被使用的技術類型等相關彙整。

第1章 調查結果

第2章 全球兒童質子治療患者數 (實際 & 潛在)

  • 兒童質子治療患者:實際的患者數與預測
  • 兒童質子治療患者:潛在患者數與預測

第3章 全球兒童質子治療市場 (實際 & 潛在)

  • 兒童質子治療市場、預測
  • 兒童質子治療:潛在市場、預測

第4章 全球兒童質子治療市場佔有率、預測

  • 各地區 (亞洲、歐洲、美國) :全球兒童質子治療市場佔有率
  • 各國:全球兒童質子治療市場佔有率

第5章 美國的兒童質子治療市場 (實際 & 潛在)

  • 美國的質子治療市場、預測
  • 美國的兒童質子治療:潛在市場、預測

第6章 美國的兒童質子治療市場:各年齡族群

  • 不滿1歲
  • 1-4歲
  • 5-9歲
  • 10-14歲
  • 15-18歲

第7章 美國的兒童質子治療患者數: (實際 & 潛在)

  • 實際的患者數與預測
  • 潛在患者數與預測

第8章 美國的兒童質子治療患者數:各年齡族群

  • 不滿1歲
  • 1-4歲
  • 5-9歲
  • 10-14歲
  • 15-18歲

第9章 腫瘤的種類:美國的兒童質子治療市場

  • 低惡性度神經膠質瘤
  • 高惡性度神經膠質瘤
  • 髓母細胞瘤
  • 室管膜瘤
  • ATRT
  • 純生殖細胞瘤
  • 生殖細胞腫瘤
  • 顱咽瘤
  • PNET
  • 松果體母細胞瘤
  • 脊索瘤/軟骨肉瘤
  • 腦膜瘤
  • AVM
  • 腺瘤
  • 脈絡叢癌症
  • 視網膜胚細胞瘤
  • 骨癌
  • 伊文氏肉瘤
  • 橫紋肌肉瘤
  • 其他肉瘤 (高惡性度)
  • 其他肉瘤 (低惡性度)
  • 畸形瘤
  • 神經母細胞瘤
  • 神經節動物膠瘤
  • 威爾姆氏腫瘤
  • 惡性腫瘤 (非CPC)
  • 何杰金氏淋巴瘤
  • 非何杰金氏淋巴瘤
  • 白血病
  • 類肌腱瘤
  • 黑色素瘤
  • 松果體實質腫瘤
  • 鼻腔神經母細胞瘤
  • 血管纖維瘤
  • 腎外類橫紋肌瘤
  • 其他

第10章 腫瘤的種類:美國的兒童質子治療患者數

  • 低惡性度神經膠質瘤
  • 高惡性度神經膠質瘤
  • 髓母細胞瘤
  • 室管膜瘤
  • ATRT
  • 純生殖細胞瘤
  • 生殖細胞腫瘤
  • 顱咽瘤
  • PNET
  • 松果體母細胞瘤
  • 脊索瘤/軟骨肉瘤
  • 腦膜瘤
  • AVM
  • 腺瘤
  • 脈絡叢癌症
  • 視網膜胚細胞瘤
  • 骨癌
  • 伊文氏肉瘤
  • 橫紋肌肉瘤
  • 其他肉瘤 (高惡性度)
  • 其他肉瘤 (低惡性度)
  • 畸形瘤
  • 神經母細胞瘤
  • 神經節動物膠瘤
  • 威爾姆氏腫瘤
  • 惡性腫瘤 (非CPC)
  • 何杰金氏淋巴瘤
  • 非何杰金氏淋巴瘤
  • 白血病
  • 類肌腱瘤
  • 黑色素瘤
  • 松果體實質腫瘤
  • 鼻腔神經母細胞瘤
  • 血管纖維瘤
  • 腎外類橫紋肌瘤
  • 其他

第11章 歐洲的兒童質子治療市場 (實際 & 潛在)

  • 市場
  • 潛在市場

第12章 歐洲的兒童質子治療患者數 (實際 & 潛在)

  • 患者數、預測
  • 潛在患者數、預測

第13章 歐洲的兒童質子治療市場佔有率:各國

第14章 法國的兒童質子治療市場: (實際 & 潛在)

第15章 法國的兒童質子治療患者數 (實際 & 潛在)

第16章 德國的兒童質子治療市場: (實際 & 潛在)

第17章 德國的兒童質子治療患者數 (實際 & 潛在)

第18章 瑞士的兒童質子治療市場: (實際 & 潛在)

第19章 瑞士的兒童質子治療患者數 (實際 & 潛在)

第20章 瑞典的兒童質子治療市場: (實際 & 潛在)

第21章 瑞典的兒童質子治療患者數 (實際 & 潛在)

第22章 捷克的兒童質子治療市場: (實際 & 潛在)

第23章 捷克的兒童質子治療患者數 (實際 & 潛在)

第24章 英國的兒童質子治療市場: (實際 & 潛在)

第25章 英國的兒童質子治療患者數 (實際 & 潛在)

第26章 亞洲的兒童質子治療市場: (實際 & 潛在)

第27章 亞洲的兒童質子治療患者數 (實際 & 潛在)

第28章 各國:亞洲的兒童質子治療市場佔有率

第29章 日本的兒童質子治療市場: (實際 & 潛在)

第30章 日本的兒童質子治療患者數 (實際 & 潛在)

第31章 中國的兒童質子治療市場: (實際 & 潛在)

第32章 中國的兒童質子治療患者數 (實際 & 潛在)

第33章 韓國的兒童質子治療市場: (實際 & 潛在)

第34章 韓國的兒童質子治療患者數 (實際 & 潛在)

第35章 質子治療中心的零組件

第36章 質子治療:促進要素

第37章 質子治療:課題

第38章 全球質子治療:企業分析

第39章 質子治療:醫療費償付政策

圖表清單

目錄

Global Pediatric Proton Therapy Market has potential of more than US$ 700 Million by 2021 . Rising pediatric cancer incidence and technological improvement to treat faster per patient will boost the pediatric proton therapy market globally.

United States is the Global Leader in Treating Pediatric Patients with Proton Therapy

USA has the highest pediatric proton therapy market share but in future it will lose its market share, due to competition from Germany, France, United Kingdom and Japan. Proton Therapy is becoming a preferential choice of treatment as its ability to treat pediatric cancer in a more efficient way, compared to traditional radiotherapy. Proton Therapy has achieved importance in such a short duration of time period, due to its technological advancement Like Intensity-Modulated Proton Therapy (IMPT) and Pencil Beam Technology.

United States Age Group of (1-4) has the highest Cancer Evidence in Pediatric Proton Therapy Market

The report captures the USA pediatric proton therapy market data on five age groups (<1) Year, (1-4) Year, (5-9) Year, (10-14) Year, (15-18) Year. In these age groups (1-4) Year has highest market.

Ependymoma Cancerous Tumor holds 15 percent market share in USA Pediatric Proton Therapy Market

The report captures 36 Type of Cancer Market & number of pediatric patients in USA. Ependymoma Cancerous Tumor holds the highest market, among all the other 36 pediatric cancer market.

Germany, United Kingdom and France will drive the Europe Pediatric Proton Therapy Market

Germany holds a significant market share in Global Pediatric Proton Therapy Market. United Kingdom is more concerned about proton therapy especially for pediatric treatment. United Kingdom NHS (National Health Service) used to send massive number of pediatric patients for the proton therapy treatment abroad. Switzerland and France are also developing new proton therapy center. France used to have maximum pediatric proton therapy market share in 2010.

Japan, China & South Korea helping the Proton Therapy Market in Asia to Grow

In Asia, Japan has already established their benchmark for the treatment of pediatric patient with proton therapy. China is more focused toward developing 8 proton therapy centers (Under-construction + Planning Phase) to serve their massive population.

Global Pediatric Proton Therapy Market & Forecast (10 Countries Market Data), Patients Treated is the 20th report published by Renub Research on Proton Therapy Market . This 330 page report with 287 figures and 7 Tables provides 10 Countries: Pediatric Proton Therapy Market, Proton Therapy Patient Numbers, Cancer Type Markets in USA, Technology being used at these Proton Therapy Centers and Reimbursement Policies. The report also studies the Proton Therapy Sales & Forecast of four companies - IBA, Varian Medical Systems, Mitsubishi and Hitachi.

Key Questions Answered in the Report?

  • What is the Global Pediatric Proton Therapy Market and its growth potential in Future?
  • What is the Number of pediatric patients treated by Proton Beam Therapy worldwide?
  • What are the reimbursement policies for Proton Therapy across the world?
  • What is the Pediatric Proton Therapy Market in United States and Forecast?
  • What is the Number of Pediatric Proton Therapy Patients by age group in United States and Forecast
  • What is the Number of Pediatric Proton Therapy Patients by tumor type in United States and Forecast
  • What is the Pediatric Proton Therapy Market size in Asia (Japan, China and South Korea) and its growth potential in future?
  • What is the Number of Pediatric Proton Therapy patients treated in Asia (Japan, China and South Korea)?
  • What is the Pediatric Proton Therapy Market in Europe (Germany, France, Sweden, Switzerland, Czech and United Kingdom) and Forecast?
  • What is the Number of Pediatric Proton Therapy Patients in Europe (Germany, France, Sweden, Switzerland, Czech and United Kingdom) and Forecast?
  • What Type of Technology is being used at Proton Therapy Centers?

Key Companies Proton Therapy Sales Analysis (2010 - 2021)

1. IBA 2. Varian Medical Systems 3. Mitsubishi 4. Hitachi

Countries Pediatric Proton Therapy Market & Number of Patients studied in the Report

1. United States 2. United Kingdom 3. Switzerland 4. Germany 5. France 6. Sweden 7. Czech Republic 8. Japan 9. Korea 10. China

Table of Contents

1. Research Findings

2. Global Pediatric Proton Therapy Number of Patients (Actual & Potential)

  • 2.1 Pediatric Patients Treated with Proton Therapy Actual Numbers & Forecast
  • 2.2 Pediatric Patients with Proton Therapy Potential Numbers & Forecast

3. Global Pediatric Proton Therapy Market (Actual & Potential)

  • 3.1 Pediatric Proton Therapy Market & Forecast
  • 3.2 Pediatric Proton Therapy - Potential Market & Forecast

4. Global Pediatric Proton Therapy Market Share & Forecast

  • 4.1 By Region (Asia, Europe, USA) - Global Pediatric Proton Therapy Market Share
  • 4.2 By Countries - Global Pediatric Proton Therapy Market Share

5. United States Pediatric Proton Therapy Market (Actual & Potential)

  • 5.1 United States Pediatric Proton Therapy Market & Forecast
  • 5.2 United States Potential Pediatric Proton Therapy Market & Forecast

6. USA Pediatric Proton Therapy Market by Age Group

  • 6.1 By Age Group (<1) Year
  • 6.2 By Age Group (1-4) Year
  • 6.3 By Age Group (5-9) Year
  • 6.4 By Age Group (10-14) Year
  • 6.5 By Age Group (15-18) Year

7. USA Pediatric Proton Therapy Patient Number - Actual and Potential

  • 7.1 USA Pediatric Patients Treated with Proton Therapy Numbers & Forecast
  • 7.2 USA Pediatric Patients with Proton Therapy Potential Numbers & Forecast

8. USA Pediatric Proton Therapy Patients Numbers by Age Group

  • 8.1 By Age (<1) Year
  • 8.2 By Age (1- 4) Year
  • 8.3 By Age (5- 9) Year
  • 8.4 By Age (10-14) Year
  • 8.5 By Age (15- 18) Year

9. Tumor Types - USA Pediatrics Proton Therapy Market (2010 - 2021)

  • 9.1 Glioma, Low Grade - Market & Forecast
  • 9.2 Glioma, High Grade - Market & Forecast
  • 9.3 Medulloblastoma - Market & Forecast
  • 9.4 Ependymoma - Market & Forecast
  • 9.5 ATRT - Market & Forecast
  • 9.6 Germinoma, Pure - Market & Forecast
  • 9.7 Germ Cell Tumor - Market & Forecast
  • 9.8 Craniopharyngioma - Market & Forecast
  • 9.9 PNET - Market & Forecast
  • 9.10 Pineoblastoma - Market & Forecast
  • 9.11 Chordoma/Chondrosarcoma - Market & Forecast
  • 9.12 Meningioma - Market & Forecast
  • 9.13 AVM - Market & Forecast
  • 9.14 Adenoma - Market & Forecast
  • 9.15 Choroid Plexus Carcinoma - Market & Forecast
  • 9.16 Retinoblastoma - Market & Forecast
  • 9.17 Osteosarcoma - Market & Forecast
  • 9.18 Ewing Sarcoma - Market & Forecast
  • 9.19 Rhabdomyosarcoma - Market & Forecast
  • 9.20 Other Sarcoma, High Grade - Market & Forecast
  • 9.21 Other Sarcoma, Low Grade - Market & Forecast
  • 9.22 Teratoma - Market & Forecast
  • 9.23 Neuroblastoma - Market & Forecast
  • 9.24 Ganglioglioma - Market & Forecast
  • 9.25 Wilm's Tumor - Market & Forecast
  • 9.26 Carcinoma (non-CPC) - Market & Forecast
  • 9.27 Lymphoma, Hodgkin's - Market & Forecast
  • 9.28 Lymphoma, Non-hodgkin's - Market & Forecast
  • 9.29 Leukemia - Market & Forecast
  • 9.30 Desmoid - Market & Forecast
  • 9.31 Melanoma - Market & Forecast
  • 9.32 Pineal Parenchymal Tumor - Market & Forecast
  • 9.33 Esthesioneuroblastoma - Market & Forecast
  • 9.34 Angiofibroma - Market & Forecast
  • 9.35 Extrarenal Rhabdoid Tumor - Market & Forecast
  • 9.36 Others - Market & Forecast

10. Tumor Types USA Pediatrics Proton Therapy Patients (2010 - 2021)

  • 10.1 Glioma, Low Grade - Patient Numbers & Forecast
  • 10.2 Glioma, High Grade - Patient Numbers & Forecast
  • 10.3 Medulloblastoma - Patient Numbers & Forecast
  • 10.4 Ependymoma - Patient Numbers & Forecast
  • 10.5 ATRT - Patient Numbers & Forecast
  • 10.6 Germinoma, pure - Patient Numbers & Forecast
  • 10.7 Germ Cell Tumor - Patient Numbers & Forecast
  • 10.8 Craniopharyngioma - Patient Numbers & Forecast
  • 10.9 PNET - Patient Numbers & Forecast
  • 10.10 Pineoblastoma - Patient Numbers & Forecast
  • 10.11 Chordoma/Chondrosarcoma - Patient Numbers & Forecast
  • 10.12 Meningioma - Patient Numbers & Forecast
  • 10.13 AVM - Patient Numbers & Forecast
  • 10.14 Adenoma - Patient Numbers & Forecast
  • 10.15 Choroid Plexus Carcinoma - Patient Numbers & Forecast
  • 10.16 Retinoblastoma - Patient Numbers & Forecast
  • 10.17 Osteosarcoma - Patient Numbers & Forecast
  • 10.18 Ewing Sarcoma - Patient Numbers & Forecast
  • 10.19 Rhabdomyosarcoma - Patient Numbers & Forecast
  • 10.20 Other Sarcoma, High Grade - Patient Numbers & Forecast
  • 10.21 Other Sarcoma, Low Grade - Patient Numbers & Forecast
  • 10.22 Teratoma - Patient Numbers & Forecast
  • 10.23 Neuroblastoma - Patient Numbers & Forecast
  • 10.24 Ganglioglioma - Patient Numbers & Forecast
  • 10.25 Wilm's Tumor - Patient Numbers & Forecast
  • 10.26 Carcinoma (non-CPC) - Patient Numbers & Forecast
  • 10.27 Lymphoma, Hodgkin's - Patient Numbers & Forecast
  • 10.28 Lymphoma, Non-hodgkin's - Patient Numbers & Forecast
  • 10.29 Leukemia - Patient Numbers & Forecast
  • 10.30 Desmoid - Patient Numbers & Forecast
  • 10.31 Melanoma - Patient Numbers & Forecast
  • 10.32 Pineal Parenchymal Tumor - Patient Numbers & Forecast
  • 10.33 Esthesioneuroblastoma - Patient Numbers & Forecast
  • 10.34 Angiofibroma - Patient Numbers & Forecast
  • 10.35 Extrarenal Rhabdoid Tumor - Patient Numbers & Forecast
  • 10.36 Others - Patient Numbers & Forecast

11. Europe Pediatric Proton Therapy Market (Actual & Potential)

  • 11.1 Europe Pediatric Proton Therapy Market
  • 11.2 Europe Pediatric Proton Therapy Potential Market

12. Europe Pediatric Proton Therapy Number of Patients (Actual & Potential)

  • 12.1 Europe - Pediatric Patients Treated with Proton Therapy Numbers & Forecast
  • 12.2 Europe - Pediatric Patients with Proton Therapy Potential Numbers & Forecast

13. Europe Pediatric Proton Therapy Market Share by Countries

14. France Pediatric Proton Therapy Market - Actual & Potential Market

  • 14.1 France - Pediatric Proton Therapy Market & Forecast
  • 14.2 France - Potential Pediatric Proton Therapy Market

15. France Pediatric Proton Therapy Patient Number - Actual and Potential

  • 15.1 France - Pediatric Patients Treated with Proton Therapy Numbers & Forecast
  • 15.2 France - Pediatric Patients with Proton Therapy Potential Numbers & Forecast

16. Germany Pediatric Proton Therapy Market - Actual & Potential Market

  • 16.1 Germany - Pediatric Proton Therapy Market & Forecast
  • 16.2 Germany - Potential Pediatric Proton Therapy Market

17. Germany Pediatric Proton Therapy Patient Number - Actual and Potential

  • 17.1 Germany - Pediatric Patients Treated with Proton Therapy Numbers & Forecast
  • 17.2 Germany - Pediatric Patients with Proton Therapy Potential Numbers & Forecast

18. Switzerland Pediatric Proton Therapy Market - Actual & Potential Market

  • 18.1 Switzerland Pediatric Proton Therapy Market & Forecast
  • 18.2 Switzerland - Pediatric Proton Therapy Potential Market & Forecast

19. Switzerland Pediatric Proton Therapy Patient Number - Actual and Potential

  • 19.1 Switzerland - Pediatric Patients Treated with Proton Therapy Numbers & Forecast
  • 19.2 Switzerland - Pediatric Patients with Proton Therapy Potential Numbers & Forecast

20. Sweden Pediatric Proton Therapy Market - Actual & Potential Market

  • 20.1 Sweden - Pediatric Proton Therapy Market & Forecast
  • 20.2 Sweden - Potential Pediatric Proton Therapy Market & Forecast

21. Sweden Pediatric Proton Therapy Patient Number - Actual and Potential

  • 21.1 Sweden - Pediatric Patients Treated with Proton Therapy Numbers & Forecast
  • 21.2 Sweden - Pediatric Patients with Proton Therapy Potential Numbers & Forecast

22. Czech Republic Pediatric Proton Therapy Market - Actual & Potential Market

  • 22.1 Czech Republic Pediatric Proton Therapy Market & Forecast
  • 22.2 Czech Republic Potential Pediatric Proton Therapy Market & Forecast

23. Czech Republic Proton Therapy Patient Number - Actual and Potential

  • 23.1 Czech Republic - Pediatric Patients Treated with Proton Therapy Numbers & Forecast
  • 23.2 Czech Republic - Pediatric Patients with Proton Therapy Potential Numbers & Forecast

24. United Kingdom Pediatric Proton Therapy Market - Actual & Potential Market

  • 24.1 United Kingdom Pediatric Proton Therapy Market & Forecast
  • 24.2 United Kingdom Pediatric Proton therapy Market with NHS Expenditure
  • 24.3 United Kingdom Pediatric Proton Therapy Potential Market & Forecast

25. United Kingdom Pediatric Proton Therapy Patient Number - Actual and Potential

  • 25.1 United Kingdom - Patients Treated with Proton Therapy Numbers & Forecast
  • 25.2 Treatment Patterns of Pediatric Patients with Proton Therapy in United Kingdom and Abroad
  • 25.3 United Kingdom - Pediatric Patients with Proton Therapy Potential Numbers & Forecast

26. Asia Pediatric Proton Therapy Market (Actual & Potential)

  • 26.1 Asia Pediatric Proton Therapy Market & Forecast
  • 26.2 Asia Pediatric Proton Therapy - Potential Market & Forecast

27. Asia Pediatric Proton Therapy Number of Patients (Actual & Potential)

  • 27.1 Asia - Pediatric Patients Treated with Proton Therapy Numbers & Forecast
  • 27.2 Asia - Pediatric Patients with Proton Therapy Potential Numbers & Forecast

28. By Countries - Asia Pediatric Proton Therapy Market Share

29. Japan Pediatric Proton Therapy - Actual & Potential Market

  • 29.1 Japan - Pediatric Proton Therapy Market & Forecast
  • 29.2 Japan - Potential Pediatric Proton Therapy Market & Forecast

30. Japan Pediatric Proton Therapy Patient Number - Actual and Potential

  • 30.1 Japan - Pediatric Patients Treated with Proton Therapy Actual Numbers & Forecast
  • 30.2 Japan - Pediatric Patients with Proton Therapy Potential Numbers & Forecast

31. China Pediatric Proton Therapy Market - Actual & Potential Market

  • 31.1 China - Pediatric Proton Therapy Market & Forecast
  • 31.2 China - Potential Pediatric Proton Therapy Market

32. China Pediatric Proton Therapy Patients Number - Actual and Potential

  • 32.1 China - Pediatric Patients Treated with Proton Therapy Numbers & Forecast
  • 32.2 China - Pediatric Patients with Proton Therapy Potential Numbers & Forecast

33. South Korea Pediatric Proton Therapy Market - Actual & Potential Market

  • 33.1 South Korea - Pediatric Proton Therapy Market & Forecast
  • 33.2 South Korea - Potential Pediatric Proton Therapy Market & Forecast

34. South Korea Pediatric Proton Therapy Patient Number - Actual and Potential

  • 34.1 South Korea - Pediatric Patients Treated with Proton Therapy Numbers & Forecast
  • 34.2 South Korea - Pediatric Patients with Proton Therapy Potential Numbers & Forecast

35. Components of a Standard Proton Therapy Center

  • 35.1 Proton Accelerator
    • 35.1.1 Synchrotrons (example: LLUMC at Loma Linda)
    • 35.1.2 Cyclotrons (example: MGH Boston)
    • 35.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)
    • 35.1.4 H-minus Synchrotrons
    • 35.1.5 Separated Sector Cyclotrons
    • 35.1.6 Super-conducting Cyclotrons
    • 35.1.7 Fast Cycling Synchrotron
  • 35.2 Beam Transport System
  • 35.3 Beam Delivery System
    • 35.3.1 The Passive Scattering Technique
    • 35.3.2 Beam Scanning
  • 35.4 Nozzle
    • 35.4.1 Single Scattering
    • 35.4.2 Double Scattering
    • 35.4.3 Uniform Scanning Nozzle
    • 35.4.4 Pencil Scanning Nozzle
  • 35.5 Treatment Planning System
  • 35.6 Image Viewers
  • 35.7 Patient Positioning System (PPS)
  • 35.8 Human Resource

36. Proton Therapy - Driving Factors

  • 36.1 Technology Advancement
  • 36.2 Rising Prevalence of Pediatric Cancer Globally

37. Proton Therapy - Challenges

  • 37.1 Requires Huge Investment
  • 37.2 Operations Challenges

38. Global Proton Therapy - Company Analysis (2010-2021)

  • 38.1 IBA Proton Therapy
    • 38.1.1 Sales Analysis
    • 38.1.2 IBA List of Proton Therapy Centers
  • 38.2 Varian Medical Systems
    • 38.2.1 Sales Analysis
  • 38.3 Mitsubishi Electric Corporation
    • 38.3.1 Sales Analysis
    • 38.3.2 Mitsubishi List of Proton Therapy Center
  • 38.4 Hitachi
    • 38.4.1 Sales Analysis
    • 38.4.2 Hitachi List of Proton Therapy Center

39. Proton Therapy - Reimbursement Policies

  • 39.1 Proton Therapy Reimbursement Policies for Patients
  • 39.2 Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers

List of Figures

  • Figure 2-1: Global - Pediatric Proton Therapy Patients (Number), 2010 - 2016
  • Figure 2-2: Global - Forecast for Pediatric Proton Therapy Patients (Number), 2017 - 2021
  • Figure 2-3: Global - Potential Pediatric Patient for Proton Therapy (Number), 2010 - 2016
  • Figure 2-4: Global - Forecast for Potential Pediatric Patient for Proton Therapy (Number), 2017 - 2021
  • Figure 3-1: Global - Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 3-2: Global - Forecast for Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 3-3: Global - Potential Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 3-4: Global - Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 4-1: Global - Pediatric Proton Beam Therapy Market Share (Percent) by Region, 2010 - 2016
  • Figure 4-2: Global - Forecast for Pediatric Proton Beam Therapy Market Share (Percent) by Region, 2017 - 2021
  • Figure 5-1: United States - Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 5-2: United States - Forecast for Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 5-3: United States - Potential Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 5-4: United States - Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 6-1: United States - Pediatric Proton Therapy Market by Age Group (<1) (Million US$), 2010 - 2016
  • Figure 6-2: United States - Forecast for Pediatric Proton Therapy Market by Age Group (<1) (Million US$), 2017 - 2021
  • Figure 6-3: United States - Pediatric Proton Therapy Market by Age Group (1-4) (Million US$), 2010 - 2016
  • Figure 6-4: United States - Forecast for Pediatric Proton Therapy Market by Age Group (1-4) (Million US$), 2017 - 2021
  • Figure 6-5: United States - Pediatric Proton Therapy Market by Age Group (5-9) (Million US$), 2010 - 2016
  • Figure 6-6: United States - Forecast for Pediatric Proton Therapy Market by Age Group (5-9) (Million US$), 2017 - 2021
  • Figure 6-7: United States - Pediatric Proton Therapy Market by Age Group (10-14) (Million US$), 2010 - 2016
  • Figure 6-8: United States - Forecast for Pediatric Proton Therapy Market by Age Group (10-14) (Million US$), 2017 - 2021
  • Figure 6-9: United States - Pediatric Proton Therapy Market by Age Group (15-18) (Million US$), 2010 - 2016
  • Figure 6-10: United States - Forecast for Pediatric Proton Therapy Market by Age Group (15-18) (Million US$), 2017 - 2021
  • Figure 7-1: United States - Pediatric Proton Therapy Patients (Number), 2010 - 2016
  • Figure 7-2: United States - Forecast for Pediatric Proton Therapy Patients (Number), 2017 - 2021
  • Figure 7-3: United States - Potential Pediatric Proton Therapy Patients (Number), 2010 - 2016
  • Figure 7-4: United States - Forecast for Potential Pediatric Proton Therapy Patients (Number), 2017 - 2021
  • Figure 8-1: United States - Pediatric Proton Therapy Patients by Age Group (<1) (Number), 2010 - 2016
  • Figure 8-2: United States - Forecast for Pediatric Proton Therapy Patients by Age Group (<1) (Number), 2017 - 2021
  • Figure 8-3: United States - Pediatric Proton Therapy Patients by Age Group (1-4) (Number), 2010 - 2016
  • Figure 8-4: United States - Forecast for Pediatric Proton Therapy Patients by Age Group (1-4) (Number), 2017 - 2021
  • Figure 8-5: United States - Pediatric Proton Therapy Patients by Age Group (5-9) (Number), 2010 - 2016
  • Figure 8-6: United States - Forecast for Pediatric Proton Therapy Patients by Age Group (5-9) (Number), 2017 - 2021
  • Figure 8-7: United States - Pediatric Proton Therapy Patients by Age Group (10-14) (Number), 2010 - 2016
  • Figure 8-8: United States - Forecast for Pediatric Proton Therapy Patients by Age Group (10-14) (Number), 2017 - 2021
  • Figure 8-9: United States - Pediatric Proton Therapy Patients by Age Group (15-18) (Number), 2010 - 2016
  • Figure 8-10: United States - Forecast for Pediatric Proton Therapy Patients by Age Group (15-18) (Number), 2017 - 2021
  • Figure 9-1: United States - Glioma, Low Grade Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-2: United States - Forecast for Glioma, Low Grade Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-3: United States - Glioma, High Grade Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-4: United States - Forecast for Glioma, High Grade Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-5: United States - Medulloblastoma Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-6: United States - Forecast for Medulloblastoma Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-7: United States - Ependymoma Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-8: United States - Forecast for Ependymoma Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-9: United States - ATRT Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-10: United States - Forecast for ATRT Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-11: United States - Germinoma, Pure Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-12: United States - Forecast for Germinoma, Pure Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-13: United States - Germ Cell Tumor Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-14: United States - Forecast for Germ Cell Tumor Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-15: United States - Craniopharyngioma Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-16: United States - Forecast for Craniopharyngioma Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-17: United States - PNET Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-18: United States - Forecast for PNET Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-19: United States - Pineoblastoma Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-20: United States - Forecast for Pineoblastoma Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-21: United States - Chordoma Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-22: United States - Forecast for Chordoma Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-23: United States - Meningioma Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-24: United States - Forecast for Meningioma Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-25: United States - AVM Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-26: United States - Forecast for AVM Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-27: United States - Adenoma Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-28: United States - Forecast for Adenoma Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-29: United States - Choroid Plexus Carcinoma Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-30: United States - Forecast for Choroid Plexus Carcinoma Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-31: United States - Retinoblastoma Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-32: United States - Forecast for Retinoblastoma Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-33: United States - Osteosarcoma Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-34: United States - Forecast for Osteosarcoma Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-35: United States - Ewing Sarcoma Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-36: United States - Forecast for Ewing sarcoma Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-37: United States - Rhabdomyosarcoma Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-38: United States - Forecast for Rhabdomyosarcoma Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-39: United States - Other Sarcoma, High Grade Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-40: United States - Forecast for Other Sarcoma, High Grade Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-41: United States - Other Sarcoma, Low Grade Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-42: United States - Forecast for Other Sarcoma, Low Grade Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-43: United States - Teratoma Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-44: United States - Forecast for Teratoma Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-45: United States - Neuroblastoma Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-46: United States - Forecast for Neuroblastoma Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-47: United States - Ganglioglioma Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-48: United States - forecast for Ganglioglioma Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-49: United States - Wilms tumor Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-50: United States - Forecast for Wilms tumor Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-51: United States - Carcinoma (non-CPC) Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-52: United States - Forecast for Carcinoma (non-CPC) Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-53: United States - Hodgkin's Lymphoma Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-54: United States - Forecast for Hodgkin's Lymphoma Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-55: United States - Non-Hodgkin Lymphoma Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-56: United States - Forecast for Non-Hodgkin Lymphoma Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-57: United States - Leukemia Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-58: United States - Forecast for Leukemia Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-59: United States - Desmoid Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-60: United States - Forecast for Desmoid Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-61: United States - Melanoma Pediatric Proton Therapy Market (Thousand US$), 2010 - 2016
  • Figure 9-62: United States - Forecast for Melanoma Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-63: United States - Pediatric Proton Therapy Market for Pineal Parenchymal Tumor (Thousand US$), 2010 - 2016
  • Figure 9-64: United States - Forecast for Pediatric Proton Therapy Market for Pineal Parenchymal Tumor (Thousand US$), 2017 - 2021
  • Figure 9-65: United States - Pediatric Proton Therapy Market for Esthesioneuroblastoma (Thousand US$), 2010 - 2016
  • Figure 9-66: United States - Forecast for Esthesioneuroblastoma Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-67: United States - Pediatric Proton Therapy Market for Angiofibroma (Thousand US$), 2010 - 2016
  • Figure 9-68: United States - Forecast for Angiofibroma Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 9-69: United States - Pediatric Proton Therapy Market for Extrarenal Rhabdoid Tumor (Thousand US$), 2010 - 2016
  • Figure 9-70: United States - Forecast for Pediatric Proton Therapy Market by Extrarenal Rhabdoid Tumor (Thousand US$), 2017 - 2021
  • Figure 9-71: United States - Pediatric Proton Therapy Market for Others (Thousand US$), 2010 - 2016
  • Figure 9-72: United States - Forecast for Others Pediatric Proton Therapy Market (Thousand US$), 2017 - 2021
  • Figure 10-1: United States - Pediatric Proton Therapy Patients by Glioma, Low Grade (Number), 2010 - 2016
  • Figure 10-2: United States - Forecast for Pediatric Proton Therapy Patients by Glioma, Low Grade (Number), 2017 - 2021
  • Figure 10-3: United States - Pediatric Proton Therapy Patients by Glioma, High Grade (Number), 2010 - 2016
  • Figure 10-4: United States - Forecast for Pediatric Proton Therapy Patients by Glioma, High Grade (Number), 2017 - 2021
  • Figure 10-5: United States - Pediatric Proton Therapy Patients by Medulloblastoma (Number), 2010 - 2016
  • Figure 10-6: United States - Forecast for Pediatric Proton Therapy Patients by Medulloblastoma (Number), 2017 - 2021
  • Figure 10-7: United States - Pediatric Proton Therapy Patients by Ependymoma (Number), 2010 - 2016
  • Figure 10-8: United States - Forecast for Pediatric Proton Therapy Patients by Ependymoma (Number), 2017 - 2021
  • Figure 10-9: United States - Pediatric Proton Therapy Patients by ATRT (Number), 2010 - 2016
  • Figure 10-10: United States - Forecast for Pediatric Proton Therapy Patients by ATRT (Number), 2017 - 2021
  • Figure 10-11: United States - Pediatric Proton Therapy Patients by Germinoma, pure (Number), 2010 - 2016
  • Figure 10-12: United States - Forecast for Pediatric Proton Therapy Patients by Germinoma, pure (Number), 2017 - 2021
  • Figure 10-13: United States - Pediatric Proton Therapy Patients by Germ Cell Tumor (Number), 2010 - 2016
  • Figure 10-14: United States - Forecast for Pediatric Proton Therapy Patients by Germ Cell Tumor (Number), 2017 - 2021
  • Figure 10-15: United States - Pediatric Proton Therapy Patients by Craniopharyngioma (Number), 2010 - 2016
  • Figure 10-16: United States - Forecast for Pediatric Proton Therapy Patients by Craniopharyngioma (Number), 2017 - 2021
  • Figure 10-17: United States - Pediatric Proton Therapy Patients by PNET (Number), 2010 - 2016
  • Figure 10-18: United States - Forecast for Pediatric Proton Therapy Patients by PNET (Number), 2017 - 2021
  • Figure 10-19: United States - Pediatric Proton Therapy Patients by Pineoblastoma (Number), 2010 - 2016
  • Figure 10-20: United States - Forecast for Pediatric Proton Therapy Patients by Pineoblastoma (Number), 2017 - 2021
  • Figure 10-21: United States - Pediatric Proton Therapy Patients by Chordoma/Chondrosarcoma (Number), 2010 - 2016
  • Figure 10-22: United States - Forecast for Pediatric Proton Therapy Patients by Chordoma/Chondrosarcoma (Number), 2017 - 2021
  • Figure 10-23: United States - Pediatric Proton Therapy Patients by Meningioma (Number), 2010 - 2016
  • Figure 10-24: United States - Forecast for Pediatric Proton Therapy Patients by Meningioma (Number), 2017 - 2021
  • Figure 10-25: United States - Pediatric Proton Therapy Patients by AVM (Number), 2010 - 2016
  • Figure 10-26: United States - Forecast for Pediatric Proton Therapy Patients by AVM (Number), 2017 - 2021
  • Figure 10-27: United States - Pediatric Proton Therapy Patients by Adenoma (Number), 2010 - 2016
  • Figure 10-28: United States - Forecast for Pediatric Proton Therapy Patients by Adenoma (Number), 2017 - 2021
  • Figure 10-29: United States - Pediatric Proton Therapy Patients by Choroid Plexus Carcinoma (Number), 2010 - 2016
  • Figure 10-30: United States - Forecast for Pediatric Proton Therapy Patients by Choroid Plexus Carcinoma (Number), 2017 - 2021
  • Figure 10-31: United States - Pediatric Proton Therapy Patients by Retinoblastoma (Number), 2010 - 2016
  • Figure 10-32: United States - Forecast for Pediatric Proton Therapy Patients by Retinoblastoma (Number), 2017 - 2021
  • Figure 10-33: United States - Pediatric Proton Therapy Patients by Osteosarcoma (Number), 2010 - 2016
  • Figure 10-34: United States - Forecast for Pediatric Proton Therapy Patients by Osteosarcoma (Number), 2017 - 2021
  • Figure 10-35: United States - Pediatric Proton Therapy Patients by Ewing Sarcoma (Number), 2010 - 2016
  • Figure 10-36: United States - Forecast for Pediatric Proton Therapy Patients by Ewing Sarcoma (Number), 2017 - 2021
  • Figure 10-37: United States - Pediatric Proton Therapy Patients by Rhabdomyosarcoma (Number), 2010 - 2016
  • Figure 10-38: United States - Forecast Pediatric Proton Therapy Patients by Rhabdomyosarcoma (Number), 2017 - 2021
  • Figure 10-39: United States - Pediatric Proton Therapy Patients by Other Sarcoma, High Grade (Number), 2010 - 2016
  • Figure 10-40: United States - Forecast for Pediatric Proton Therapy Patients by Other Sarcoma, High Grade (Number), 2017 - 2021
  • Figure 10-41: United States - Pediatric Proton Therapy Patients by Other Sarcoma, Low Grade (Number), 2010 - 2016
  • Figure 10-42: United States - Forecast for Pediatric Proton Therapy Patients by Other Sarcoma, Low Grade (Number), 2017 - 2021
  • Figure 10-43: United States - Pediatric Proton Therapy Patients by Teratoma (Number), 2010 - 2016
  • Figure 10-44: United States - Forecast for Pediatric Proton Therapy Patients by Teratoma (Number), 2017 - 2021
  • Figure 10-45: United States - Pediatric Proton Therapy Patients by Neuroblastoma (Number), 2010 - 2016
  • Figure 10-46: United States - Forecast for Pediatric Proton Therapy Patients by Neuroblastoma (Number), 2017 - 2021
  • Figure 10-47: United States - Pediatric Proton Therapy Patients by Ganglioglioma (Number), 2010 - 2016
  • Figure 10-48: United States - Forecast for Pediatric Proton Therapy Patients by Ganglioglioma (Number), 2017 - 2021
  • Figure 10-49: United States - Pediatric Proton Therapy Patients by Wilm's Tumor (Number), 2010 - 2016
  • Figure 10-50: United States - Forecast for Pediatric Proton Therapy Patients by Wilm's Tumor (Number), 2017 - 2021
  • Figure 10-51: United States - Pediatric Proton Therapy Patients by Carcinoma (non-CPC) (Number), 2010 - 2016
  • Figure 10-52: United States - Forecast for Pediatric Proton Therapy Patients by Carcinoma (non-CPC) (Number), 2017 - 2021
  • Figure 10-53: United States - Pediatric Proton Therapy Patients by Lymphoma, Hodgkin's (Number), 2010 - 2016
  • Figure 10-54: United States - Forecast for Pediatric Proton Therapy Patients by Lymphoma, Hodgkin's (Number), 2017 - 2021
  • Figure 10-55: United States - Pediatric Proton Therapy Patients by Lymphoma, Non-hodgkin's (Number), 2010 - 2016
  • Figure 10-56: United States - Forecast for Pediatric Proton Therapy Patients by Lymphoma, Non-hodgkin's (Number), 2010 - 2016
  • Figure 10-57: United States - Pediatric Proton Therapy Patients by Leukemia (Number), 2010 - 2016
  • Figure 10-58: United States - Forecast for Pediatric Proton Therapy Patients by Leukemia (Number), 2017 - 2021
  • Figure 10-59: United States - Pediatric Proton Therapy Patients by Desmoid (Number), 2010 - 2016
  • Figure 10-60: United States - Forecast for Pediatric Proton Therapy Patients by Desmoid (Number), 2017 - 2021
  • Figure 10-61: United States - Pediatric Proton Therapy Patients by Melanoma (Number), 2010 - 2016
  • Figure 10-62: United States - Forecast for Pediatric Proton Therapy Patients by Melanoma (Number), 2017 - 2021
  • Figure 10-63: United States - Pediatric Proton Therapy Patients by Pineal Parenchymal Tumor (Number), 2010 - 2016
  • Figure 10-64: United States - Forecast for Pediatric Proton Therapy Patients by Pineal Parenchymal Tumor (Number), 2017 - 2021
  • Figure 10-65: United States - Pediatric Proton Therapy Patients by Esthesioneuroblastoma (Number), 2010 - 2016
  • Figure 10-66: United States - Forecast for Pediatric Proton Therapy Patients by Esthesioneuroblastoma (Number), 2017 - 2021
  • Figure 10-67: United States - Pediatric Proton Therapy Patients by Angiofibroma (Number), 2010 - 2016
  • Figure 10-68: United States - Forecast for Pediatric Proton Therapy Patients by Angiofibroma (Number), 2017 - 2021
  • Figure 10-69: United States - Pediatric Proton Therapy Patients by Extrarenal Rhabdoid Tumor (Number), 2010 - 2016
  • Figure 10-70: United States - Forecast for Pediatric Proton Therapy Patients by Extrarenal Rhabdoid Tumor (Number), 2017 - 2021
  • Figure 10-71: United States - Pediatric Proton Therapy Patients by Others (Number), 2010 - 2016
  • Figure 10-72: United States - Forecast for Pediatric Proton Therapy Patients by Others (Number), 2017 - 2021
  • Figure 11-1: Europe - Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 11-2: Europe - Forecast for Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 11-3: Europe - Potential Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 11-4: Europe - Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 12-1: Europe - Pediatric Proton Therapy Patients (Number), 2010 - 2016
  • Figure 12-2: Europe - Forecast for Pediatric Proton Therapy Patients (Number), 2017 - 2021
  • Figure 12-3: Europe - Potential Pediatric Patient for Proton Therapy (Number), 2010 - 2016
  • Figure 12-4: Europe - Forecast for Potential Pediatric Patient for Proton Therapy (Number), 2017 - 2021
  • Figure 13-1: Europe - Pediatric Proton Therapy Market Share (Percent) by Countries, 2010 - 2016
  • Figure 13-2: Europe - Forecast for Pediatric Proton Therapy Market Share (Percent) by Countries, 2017 - 2021
  • Figure 14-1: France - Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 14-2: France - Forecast for Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 14-3: France - Potential Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 14-4: France - Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 15-1: France - Pediatric Proton Therapy Patients (Number), 2010 - 2016
  • Figure 15-2: France - Forecast for Pediatric Proton Therapy Patients (Number), 2017 - 2021
  • Figure 15-3: France - Potential Pediatric Patient for Proton Therapy (Number), 2010 - 2016
  • Figure 15-4: France - Forecast for Potential Pediatric Proton Therapy Patient (Number), 2017 - 2021
  • Figure 16-1: Germany - Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 16-2: Germany - Forecast for Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 16-3: Germany - Potential Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 16-4: Germany - Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 17-1: Germany - Pediatric Proton Therapy Patients (Number), 2010 - 2016
  • Figure 17-2: Germany - Forecast for Pediatric Proton Therapy Patients (Number), 2017 - 2021
  • Figure 17-3: Germany - Potential Pediatric Patient for Proton Therapy (Number), 2010 - 2016
  • Figure 17-4: Germany - Forecast for Potential Pediatric Proton Therapy Patient (Number), 2017 - 2021
  • Figure 18-1: Switzerland - Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 18-2: Switzerland - Forecast for Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 18-3: Switzerland - Potential Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 18-4: Switzerland - Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 19-1: Switzerland - Pediatric Proton Therapy Patients (Number), 2010 - 2016
  • Figure 19-2: Switzerland - Forecast for Pediatric Proton Therapy Patients (Number), 2017 - 2021
  • Figure 19-3: Switzerland - Potential Pediatric Patient for Proton Therapy (Number), 2010 - 2016
  • Figure 19-4: Switzerland - Forecast for Potential Pediatric Proton Therapy Patient (Number), 2017 - 2021
  • Figure 20-1: Sweden - Pediatric Proton Therapy Market (Million US$), 2011 - 2016
  • Figure 20-2: Sweden - Forecast for Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 20-3: Sweden - Potential Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 20-4: Sweden - Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 21-1: Sweden - Pediatric Proton Therapy Patients (Number), 2011 - 2016
  • Figure 21-2: Sweden - Pediatric Proton Therapy Patients (Number), 2017 - 2021
  • Figure 21-3: Sweden - Potential Pediatric Patient for Proton Therapy (Number), 2010 - 2016
  • Figure 21-4: Sweden - Forecast for Potential Pediatric Proton Therapy Patient (Number), 2017 - 2021
  • Figure 22-1: Czech Republic - Pediatric Proton Therapy Market (Million US$), 2013 - 2016
  • Figure 22-2: Czech Republic - Forecast for Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 22-3: Czech Republic - Potential Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 22-4: Czech Republic - Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 23-1: Czech Republic - Pediatric Proton Therapy Patients (Number), 2013 - 2016
  • Figure 23-2: Czech Republic - Forecast for Pediatric Proton Therapy Patients (Number), 2017 - 2021
  • Figure 23-3: Czech Republic - Potential Pediatric Proton Therapy Patients (Number), 2010 - 2016
  • Figure 23-4: Czech Republic - Forecast for Potential Pediatric Proton Therapy Patients (Number), 2017 - 2021
  • Figure 24-1: United Kingdom - Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 24-2: United Kingdom - Forecast for Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 24-3: United Kingdom - Pediatric Proton Therapy Market and NHS Expenditure (Million US$), 2010 - 2016
  • Figure 24-4: United Kingdom - Forecast for Pediatric Proton Therapy Market and NHS Expenditure (Million US$), 2010 - 2016
  • Figure 24-5: United Kingdom - Potential Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 24-6: United Kingdom - Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 25-1: United Kingdom - Pediatric Proton Therapy Patients (Number), 2010 - 2016
  • Figure 25-2: United Kingdom - Forecast for Pediatric Proton Therapy Patients (Number), 2017 - 2021
  • Figure 25-3: United Kingdom - Forecast for Proportion of Pediatric Proton Therapy Patients in U.K and Abroad (Number), 2017 - 2021
  • Figure 25-4: United Kingdom - Potential Pediatric Proton Therapy Patients (Number), 2010 - 2016
  • Figure 25-5: United Kingdom - Forecast for Potential Pediatric Proton Therapy Patients (Number), 2017 - 2021
  • Figure 26-1: Asia - Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 26-2: Asia - Forecast for Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 26-3: Asia - Potential Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 26-4: Asia - Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 27-1: Asia - Pediatric Proton Therapy Patients (Number), 2010 - 2016
  • Figure 27-2: Asia - Forecast for Pediatric Proton Therapy Patients (Number), 2017 - 2021
  • Figure 27-3: Asia - Potential Pediatric Patient for Proton Therapy (Number), 2010 - 2016
  • Figure 27-4: Asia - Forecast for Potential Pediatric Patient for Proton Therapy (Number), 2017 - 2021
  • Figure 28-1: Asia - Pediatric Proton Therapy Market Share (Percent) by Countries, 2010 - 2016
  • Figure 28-2: Asia - Forecast for Pediatric Proton Therapy Market Share (Percent) by Countries, 2017 - 2021
  • Figure 29-1: Japan - Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 29-2: Japan - Forecast for Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 29-3: Japan - Potential Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 29-4: Japan - Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 30-1: Japan - Pediatric Proton Therapy Patients (Number), 2010 - 2016
  • Figure 30-2: Japan - Forecast for Pediatric Proton Therapy Patients (Number), 2017 - 2021
  • Figure 30-3: Japan - Potential Pediatric Patient for Proton Therapy (Number), 2010 - 2016
  • Figure 30-4: Japan - Forecast for Proton Therapy Potential Pediatric Patient (Number), 2017 - 2021
  • Figure 31-1: China - Pediatric Proton Therapy Market (Million US$), 2014 - 2016
  • Figure 31-2: China - Forecast for Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 31-3: China - Potential Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 31-4: China - Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 32-1: China - Pediatric Proton Therapy Patients (Number), 2014 - 2016
  • Figure 32-2: China - Forecast for Pediatric Proton Therapy Patients (Number), 2017 - 2021
  • Figure 32-3: China - Potential Pediatric Patient for Proton Therapy (Number), 2010 - 2016
  • Figure 32-4: China - Forecast for Potential Pediatric Patient with Proton Therapy (Number), 2017 - 2021
  • Figure 33-1: South Korea - Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 33-2: South Korea - Forecast for Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 33-3: South Korea - Potential Pediatric Proton Therapy Market (Million US$), 2010 - 2016
  • Figure 33-4: South Korea - Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 - 2021
  • Figure 34-1: South Korea - Pediatric Proton Therapy Patients (Number), 2010 - 2016
  • Figure 34-2: South Korea - Forecast for Pediatric Proton Therapy Patients (Number), 2017 - 2021
  • Figure 34-3: South Korea - Potential Pediatric Patient for Proton Therapy (Number), 2010 - 2016
  • Figure 34-4: South Korea - Forecast Potential Pediatric Patient with Proton Therapy (Number), 2017 - 2021
  • Figure 36-1: Global - Pediatric Patient Diagnosed With Cancer (Number), 2010 - 2016
  • Figure 36-2: Global - Forecast for Pediatric Patient Diagnosed With Cancer (Number), 2017 - 2022
  • Figure 38-1: Global - IBA Proton Therapy Sales (Million US$), 2010 - 2016
  • Figure 38-2: Global - Forecast for IBA Proton Therapy Sales (Million US$), 2017 - 2021
  • Figure 38-3: Global - Varian Medical Systems Oncology Systems Sales (Million US$), 2010 - 2016
  • Figure 38-4: Global - Forecast for Varian Medical Systems Oncology Systems Sales (Million US$), 2017 - 2021
  • Figure 38-5: Global - Mitsubishi Electric Corporation Energy and Electric Systems Sales (Million US$), 2010 - 2016
  • Figure 38-6: Global - Forecast for Mitsubishi Electric Corporation Energy and Electric Systems Sales (Million US$), 2017 - 2021
  • Figure 38-7: Global - Hitachi Electronic Systems and Equipment Sales (Million US$), 2010 - 2016
  • Figure 38-8: Global - Forecast for Hitachi Electronic Systems and Equipment Sales (Million US$), 2017 - 2021

List of Tables

  • Table 3-1: Global - IBA Multiple Room Proton Therapy Center
  • Table 4-1: Global - Pediatric Proton Beam Therapy Market Share (Percent) by Countries, 2010 - 2016
  • Table 4-2: Global - Forecast for Pediatric Proton Beam Therapy Market Share (Percent) by Countries, 2017 - 2021
  • Table 24-1: United Kingdom - Under-Construction Proton Therapy Center with Operational Launch Year
  • Table 38-1: Global - IBA Proton Therapy Centers in Operational and Under-Construction Phase
  • Table 38-2: Global - Mitsubishi Proton Therapy Centers in Operational and Under-Construction Phase
  • Table 38-3: Global - Hitachi Proton Therapy Centers in Operational and Under-Construction Phase
Back to Top